|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CLPTM1L-CDHR2 (FusionGDB2 ID:17309) |
Fusion Gene Summary for CLPTM1L-CDHR2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CLPTM1L-CDHR2 | Fusion gene ID: 17309 | Hgene | Tgene | Gene symbol | CLPTM1L | CDHR2 | Gene ID | 81037 | 54825 |
| Gene name | CLPTM1 like | cadherin related family member 2 | |
| Synonyms | CRR9 | PCDH24|PCLKC | |
| Cytomap | 5p15.33 | 5q35.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cleft lip and palate transmembrane protein 1-like proteinCLPTM1-like proteincisplatin resistance related protein CRR9pcisplatin resistance-related protein 9 | cadherin-related family member 2protocadherin-24 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q96KA5 | Q9BYE9 | |
| Ensembl transtripts involved in fusion gene | ENST00000320895, ENST00000320927, ENST00000507807, ENST00000506641, | ENST00000261944, ENST00000506348, ENST00000510636, | |
| Fusion gene scores | * DoF score | 11 X 10 X 8=880 | 3 X 3 X 3=27 |
| # samples | 11 | 5 | |
| ** MAII score | log2(11/880*10)=-3 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/27*10)=0.888968687611256 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CLPTM1L [Title/Abstract] AND CDHR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CLPTM1L(1341786)-CDHR2(176008344), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CDHR2 | GO:0030855 | epithelial cell differentiation | 12117771 |
| Tgene | CDHR2 | GO:0044331 | cell-cell adhesion mediated by cadherin | 12117771 |
| Tgene | CDHR2 | GO:0060243 | negative regulation of cell growth involved in contact inhibition | 12117771 |
| Fusion gene breakpoints across CLPTM1L (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CDHR2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | KIRC | TCGA-BP-5175-01A | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
Top |
Fusion Gene ORF analysis for CLPTM1L-CDHR2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000320895 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000320895 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000320895 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000320927 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000320927 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000320927 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000507807 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000507807 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| In-frame | ENST00000507807 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| intron-3CDS | ENST00000506641 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| intron-3CDS | ENST00000506641 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| intron-3CDS | ENST00000506641 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000320895 | CLPTM1L | chr5 | 1341786 | - | ENST00000510636 | CDHR2 | chr5 | 176008344 | + | 3128 | 711 | 216 | 2825 | 869 |
| ENST00000320895 | CLPTM1L | chr5 | 1341786 | - | ENST00000261944 | CDHR2 | chr5 | 176008344 | + | 2922 | 711 | 216 | 2825 | 869 |
| ENST00000320895 | CLPTM1L | chr5 | 1341786 | - | ENST00000506348 | CDHR2 | chr5 | 176008344 | + | 2851 | 711 | 216 | 2825 | 869 |
| ENST00000507807 | CLPTM1L | chr5 | 1341786 | - | ENST00000510636 | CDHR2 | chr5 | 176008344 | + | 2485 | 68 | 2 | 2182 | 726 |
| ENST00000507807 | CLPTM1L | chr5 | 1341786 | - | ENST00000261944 | CDHR2 | chr5 | 176008344 | + | 2279 | 68 | 2 | 2182 | 726 |
| ENST00000507807 | CLPTM1L | chr5 | 1341786 | - | ENST00000506348 | CDHR2 | chr5 | 176008344 | + | 2208 | 68 | 2 | 2182 | 726 |
| ENST00000320927 | CLPTM1L | chr5 | 1341786 | - | ENST00000510636 | CDHR2 | chr5 | 176008344 | + | 2913 | 496 | 1 | 2610 | 869 |
| ENST00000320927 | CLPTM1L | chr5 | 1341786 | - | ENST00000261944 | CDHR2 | chr5 | 176008344 | + | 2707 | 496 | 1 | 2610 | 869 |
| ENST00000320927 | CLPTM1L | chr5 | 1341786 | - | ENST00000506348 | CDHR2 | chr5 | 176008344 | + | 2636 | 496 | 1 | 2610 | 869 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000320895 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.001736156 | 0.9982639 |
| ENST00000320895 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.002353303 | 0.99764663 |
| ENST00000320895 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.002447689 | 0.99755234 |
| ENST00000507807 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.002785113 | 0.9972149 |
| ENST00000507807 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.003971091 | 0.9960289 |
| ENST00000507807 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.004234516 | 0.99576545 |
| ENST00000320927 | ENST00000510636 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.00190872 | 0.9980913 |
| ENST00000320927 | ENST00000261944 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.002618221 | 0.99738175 |
| ENST00000320927 | ENST00000506348 | CLPTM1L | chr5 | 1341786 | - | CDHR2 | chr5 | 176008344 | + | 0.002737059 | 0.99726295 |
Top |
Fusion Genomic Features for CLPTM1L-CDHR2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| CLPTM1L | chr5 | 1341785 | - | CDHR2 | chr5 | 176008343 | + | 2.46E-09 | 1 |
| CLPTM1L | chr5 | 1341785 | - | CDHR2 | chr5 | 176008343 | + | 2.46E-09 | 1 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for CLPTM1L-CDHR2 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:1341786/chr5:176008344) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CLPTM1L | CDHR2 |
| FUNCTION: Enhances cisplatin-mediated apoptosis, when overexpressed. {ECO:0000269|PubMed:11162647}. | FUNCTION: Intermicrovillar adhesion molecule that forms, via its extracellular domain, calcium-dependent heterophilic complexes with CDHR5 on adjacent microvilli. Thereby, controls the packing of microvilli at the apical membrane of epithelial cells. Through its cytoplasmic domain, interacts with microvillus cytoplasmic proteins to form the intermicrovillar adhesion complex/IMAC. This complex plays a central role in microvilli and epithelial brush border differentiation (PubMed:24725409). May also play a role in cell-cell adhesion and contact inhibition in epithelial cells (PubMed:12117771). {ECO:0000269|PubMed:12117771, ECO:0000269|PubMed:24725409}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 1_10 | 151 | 539.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 1_10 | 151 | 503.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 11_31 | 151 | 539.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 11_31 | 151 | 503.0 | Transmembrane | Helical |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 696_808 | 606 | 1311.0 | Domain | Cadherin 7 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 810_928 | 606 | 1311.0 | Domain | Cadherin 8 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 930_1058 | 606 | 1311.0 | Domain | Cadherin 9 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 696_808 | 606 | 1311.0 | Domain | Cadherin 7 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 810_928 | 606 | 1311.0 | Domain | Cadherin 8 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 930_1058 | 606 | 1311.0 | Domain | Cadherin 9 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 696_808 | 606 | 1311.0 | Domain | Cadherin 7 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 810_928 | 606 | 1311.0 | Domain | Cadherin 8 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 930_1058 | 606 | 1311.0 | Domain | Cadherin 9 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 1176_1310 | 606 | 1311.0 | Topological domain | Cytoplasmic | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 1176_1310 | 606 | 1311.0 | Topological domain | Cytoplasmic | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 1176_1310 | 606 | 1311.0 | Topological domain | Cytoplasmic | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 1155_1175 | 606 | 1311.0 | Transmembrane | Helical | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 1155_1175 | 606 | 1311.0 | Transmembrane | Helical | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 1155_1175 | 606 | 1311.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 306_324 | 151 | 539.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 32_284 | 151 | 539.0 | Topological domain | Extracellular |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 343_346 | 151 | 539.0 | Topological domain | Extracellular |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 365_402 | 151 | 539.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 424_428 | 151 | 539.0 | Topological domain | Extracellular |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 450_538 | 151 | 539.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 306_324 | 151 | 503.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 32_284 | 151 | 503.0 | Topological domain | Extracellular |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 343_346 | 151 | 503.0 | Topological domain | Extracellular |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 365_402 | 151 | 503.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 424_428 | 151 | 503.0 | Topological domain | Extracellular |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 450_538 | 151 | 503.0 | Topological domain | Cytoplasmic |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 285_305 | 151 | 539.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 325_342 | 151 | 539.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 347_364 | 151 | 539.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 403_423 | 151 | 539.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320895 | - | 3 | 17 | 429_449 | 151 | 539.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 285_305 | 151 | 503.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 325_342 | 151 | 503.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 347_364 | 151 | 503.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 403_423 | 151 | 503.0 | Transmembrane | Helical |
| Hgene | CLPTM1L | chr5:1341786 | chr5:176008344 | ENST00000320927 | - | 3 | 16 | 429_449 | 151 | 503.0 | Transmembrane | Helical |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 125_241 | 606 | 1311.0 | Domain | Cadherin 2 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 242_353 | 606 | 1311.0 | Domain | Cadherin 3 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 27_124 | 606 | 1311.0 | Domain | Cadherin 1 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 368_480 | 606 | 1311.0 | Domain | Cadherin 4 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 481_586 | 606 | 1311.0 | Domain | Cadherin 5 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 586_695 | 606 | 1311.0 | Domain | Cadherin 6 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 125_241 | 606 | 1311.0 | Domain | Cadherin 2 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 242_353 | 606 | 1311.0 | Domain | Cadherin 3 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 27_124 | 606 | 1311.0 | Domain | Cadherin 1 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 368_480 | 606 | 1311.0 | Domain | Cadherin 4 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 481_586 | 606 | 1311.0 | Domain | Cadherin 5 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 586_695 | 606 | 1311.0 | Domain | Cadherin 6 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 125_241 | 606 | 1311.0 | Domain | Cadherin 2 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 242_353 | 606 | 1311.0 | Domain | Cadherin 3 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 27_124 | 606 | 1311.0 | Domain | Cadherin 1 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 368_480 | 606 | 1311.0 | Domain | Cadherin 4 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 481_586 | 606 | 1311.0 | Domain | Cadherin 5 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 586_695 | 606 | 1311.0 | Domain | Cadherin 6 | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000261944 | 15 | 32 | 21_1154 | 606 | 1311.0 | Topological domain | Extracellular | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000506348 | 14 | 31 | 21_1154 | 606 | 1311.0 | Topological domain | Extracellular | |
| Tgene | CDHR2 | chr5:1341786 | chr5:176008344 | ENST00000510636 | 15 | 32 | 21_1154 | 606 | 1311.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for CLPTM1L-CDHR2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >17309_17309_1_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320895_CDHR2_chr5_176008344_ENST00000261944_length(transcript)=2922nt_BP=711nt ACTTCCGGCAGGCGGCGGGGCCCGGAAGCGGCGCGCGGGGCCGGCGAATCCCGCGGCGCCAGGTGGGAGCGGGGCCGGAGCATGCGGGGC GGCCGGCGGTCTGCGGCGCGCGGCGCATTCGTTCCCCCGCGGCGGTGGCGGTGGCGCGCGGCGGCTCTCCAGTGAGCGGCGGAGCCCGGA GCGGCGGGCTGGGCGCCGGGCGGGCGGGGCTCGCGGCTGAGAGGCGGGCGGGCCGGGGGCGCCGGGCGCGGGGCCGCCATGTGGAGCGGC CGCAGCTCCTTCACCAGCTTGGTGGTGGGCGTGTTCGTGGTCTACGTGGTGCACACCTGCTGGGTCATGTACGGCATCGTCTACACCCGC CCGTGCTCCGGCGACGCCAACTGCATCCAGCCCTACCTGGCGCGGCGGCCCAAGCTGCAGCTGAGCGTGTACACCACGACGAGGTCCCAC CTGGGTGCTGAGAACAACATCGACCTGGTCTTGAATGTGGAAGACTTTGATGTGGAGTCCAAATTTGAAAGGACAGTTAATGTTTCTGTA CCAAAGAAAACGAGAAACAATGGGACGCTGTATGCCTACATCTTCCTCCATCACGCTGGGGTCCTGCCGTGGCACGACGGGAAGCAGGTG CACCTGGTCAGTCCTCTGACCACCTACATGGTCCCCAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGAC AATGATGAGCCGGGCACCAACAACAGCCGTCTGCTCTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACA GGGCTCCTCAGAAACCTGGGGCCCCTGGACAGAGAGGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGAC TGCGGCGAGCCTGTCCTCGGCACCAAAGTCAATGTCACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGC TACAACTTTACGGTGAAGGAGGAGGATCCAGGAGTGCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGC ATCAGCTTCAGCCTGTCGGGGAGTGGTGCCAACTACTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGG CTGCCCCCGGACGTGAGCCTGGATTACGAGACACAGCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAG ACCATAGTAGACGTCTGCGTGAATGTGAAAGACGTGAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCT GAGAATGGCTCACAGCACGGCCAGGTGGCTGTGGTGGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATT CTCTGCACCAAGGCCGGGGTCGATGTGGGCAGCCTATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGC AAAGCCATCGACTACGAGGCCTGTGACCTGGTCACGCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGC AACAATGGAAGCCTCCTCATTACCATTGAGGACGTGAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCT GAACTCGTGCTGCCCAACCGGGAGGTGGCTTCTGTCCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTC CGAGTAGACTTCATCTCTAAGGACGGGGCCACCATCCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCT GGGAGCATTCAGCCGGTGACCAGCCTCGACTCCACTCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGT CCTTTCCTGGAAGCCACCACCACCCTGAATCTCTTCACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAG GTGGGCGCCAACAGACAGGCGATTAATGCGGCTCTTACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCT GCAGCTCGGGCCCGACCTCACTCCTACCTCGATGCCTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATG ATCCGGAATGATCAGGACTCGCTGACGCAGCTGCTGCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCG AAACAGCTCATCAGTGTCATCATAGGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAG AGCTACAACCGGAAGCTTCAAGCTATGAAGGCTGCCAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCA GGGACTAACATGTACAACACTGAGCGAGCCAACCCCATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAAT GACCTGGACTCTGTCAGCGTCAACTCCCTGGACGACAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCA CACACACCACCAGAGCCAGATCCAGAGCCCCTGAGCGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCC TACACCAACGCTGGCCTGGACACCACGGACCTGTGACAGGGGCCCCCACTCTTCTGGACCCCTTGAAGAGGCCCTACCACACCCTAACTG >17309_17309_1_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320895_CDHR2_chr5_176008344_ENST00000261944_length(amino acids)=869AA_BP=164 MRGGRAGGAGRGAAMWSGRSSFTSLVVGVFVVYVVHTCWVMYGIVYTRPCSGDANCIQPYLARRPKLQLSVYTTTRSHLGAENNIDLVLN VEDFDVESKFERTVNVSVPKKTRNNGTLYAYIFLHHAGVLPWHDGKQVHLVSPLTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLL FNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGV LVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDV NDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVT LVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATI PFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAAL TQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGV ALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDD -------------------------------------------------------------- >17309_17309_2_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320895_CDHR2_chr5_176008344_ENST00000506348_length(transcript)=2851nt_BP=711nt ACTTCCGGCAGGCGGCGGGGCCCGGAAGCGGCGCGCGGGGCCGGCGAATCCCGCGGCGCCAGGTGGGAGCGGGGCCGGAGCATGCGGGGC GGCCGGCGGTCTGCGGCGCGCGGCGCATTCGTTCCCCCGCGGCGGTGGCGGTGGCGCGCGGCGGCTCTCCAGTGAGCGGCGGAGCCCGGA GCGGCGGGCTGGGCGCCGGGCGGGCGGGGCTCGCGGCTGAGAGGCGGGCGGGCCGGGGGCGCCGGGCGCGGGGCCGCCATGTGGAGCGGC CGCAGCTCCTTCACCAGCTTGGTGGTGGGCGTGTTCGTGGTCTACGTGGTGCACACCTGCTGGGTCATGTACGGCATCGTCTACACCCGC CCGTGCTCCGGCGACGCCAACTGCATCCAGCCCTACCTGGCGCGGCGGCCCAAGCTGCAGCTGAGCGTGTACACCACGACGAGGTCCCAC CTGGGTGCTGAGAACAACATCGACCTGGTCTTGAATGTGGAAGACTTTGATGTGGAGTCCAAATTTGAAAGGACAGTTAATGTTTCTGTA CCAAAGAAAACGAGAAACAATGGGACGCTGTATGCCTACATCTTCCTCCATCACGCTGGGGTCCTGCCGTGGCACGACGGGAAGCAGGTG CACCTGGTCAGTCCTCTGACCACCTACATGGTCCCCAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGAC AATGATGAGCCGGGCACCAACAACAGCCGTCTGCTCTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACA GGGCTCCTCAGAAACCTGGGGCCCCTGGACAGAGAGGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGAC TGCGGCGAGCCTGTCCTCGGCACCAAAGTCAATGTCACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGC TACAACTTTACGGTGAAGGAGGAGGATCCAGGAGTGCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGC ATCAGCTTCAGCCTGTCGGGGAGTGGTGCCAACTACTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGG CTGCCCCCGGACGTGAGCCTGGATTACGAGACACAGCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAG ACCATAGTAGACGTCTGCGTGAATGTGAAAGACGTGAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCT GAGAATGGCTCACAGCACGGCCAGGTGGCTGTGGTGGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATT CTCTGCACCAAGGCCGGGGTCGATGTGGGCAGCCTATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGC AAAGCCATCGACTACGAGGCCTGTGACCTGGTCACGCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGC AACAATGGAAGCCTCCTCATTACCATTGAGGACGTGAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCT GAACTCGTGCTGCCCAACCGGGAGGTGGCTTCTGTCCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTC CGAGTAGACTTCATCTCTAAGGACGGGGCCACCATCCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCT GGGAGCATTCAGCCGGTGACCAGCCTCGACTCCACTCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGT CCTTTCCTGGAAGCCACCACCACCCTGAATCTCTTCACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAG GTGGGCGCCAACAGACAGGCGATTAATGCGGCTCTTACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCT GCAGCTCGGGCCCGACCTCACTCCTACCTCGATGCCTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATG ATCCGGAATGATCAGGACTCGCTGACGCAGCTGCTGCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCG AAACAGCTCATCAGTGTCATCATAGGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAG AGCTACAACCGGAAGCTTCAAGCTATGAAGGCTGCCAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCA GGGACTAACATGTACAACACTGAGCGAGCCAACCCCATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAAT GACCTGGACTCTGTCAGCGTCAACTCCCTGGACGACAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCA CACACACCACCAGAGCCAGATCCAGAGCCCCTGAGCGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCC >17309_17309_2_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320895_CDHR2_chr5_176008344_ENST00000506348_length(amino acids)=869AA_BP=164 MRGGRAGGAGRGAAMWSGRSSFTSLVVGVFVVYVVHTCWVMYGIVYTRPCSGDANCIQPYLARRPKLQLSVYTTTRSHLGAENNIDLVLN VEDFDVESKFERTVNVSVPKKTRNNGTLYAYIFLHHAGVLPWHDGKQVHLVSPLTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLL FNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGV LVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDV NDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVT LVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATI PFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAAL TQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGV ALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDD -------------------------------------------------------------- >17309_17309_3_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320895_CDHR2_chr5_176008344_ENST00000510636_length(transcript)=3128nt_BP=711nt ACTTCCGGCAGGCGGCGGGGCCCGGAAGCGGCGCGCGGGGCCGGCGAATCCCGCGGCGCCAGGTGGGAGCGGGGCCGGAGCATGCGGGGC GGCCGGCGGTCTGCGGCGCGCGGCGCATTCGTTCCCCCGCGGCGGTGGCGGTGGCGCGCGGCGGCTCTCCAGTGAGCGGCGGAGCCCGGA GCGGCGGGCTGGGCGCCGGGCGGGCGGGGCTCGCGGCTGAGAGGCGGGCGGGCCGGGGGCGCCGGGCGCGGGGCCGCCATGTGGAGCGGC CGCAGCTCCTTCACCAGCTTGGTGGTGGGCGTGTTCGTGGTCTACGTGGTGCACACCTGCTGGGTCATGTACGGCATCGTCTACACCCGC CCGTGCTCCGGCGACGCCAACTGCATCCAGCCCTACCTGGCGCGGCGGCCCAAGCTGCAGCTGAGCGTGTACACCACGACGAGGTCCCAC CTGGGTGCTGAGAACAACATCGACCTGGTCTTGAATGTGGAAGACTTTGATGTGGAGTCCAAATTTGAAAGGACAGTTAATGTTTCTGTA CCAAAGAAAACGAGAAACAATGGGACGCTGTATGCCTACATCTTCCTCCATCACGCTGGGGTCCTGCCGTGGCACGACGGGAAGCAGGTG CACCTGGTCAGTCCTCTGACCACCTACATGGTCCCCAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGAC AATGATGAGCCGGGCACCAACAACAGCCGTCTGCTCTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACA GGGCTCCTCAGAAACCTGGGGCCCCTGGACAGAGAGGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGAC TGCGGCGAGCCTGTCCTCGGCACCAAAGTCAATGTCACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGC TACAACTTTACGGTGAAGGAGGAGGATCCAGGAGTGCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGC ATCAGCTTCAGCCTGTCGGGGAGTGGTGCCAACTACTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGG CTGCCCCCGGACGTGAGCCTGGATTACGAGACACAGCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAG ACCATAGTAGACGTCTGCGTGAATGTGAAAGACGTGAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCT GAGAATGGCTCACAGCACGGCCAGGTGGCTGTGGTGGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATT CTCTGCACCAAGGCCGGGGTCGATGTGGGCAGCCTATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGC AAAGCCATCGACTACGAGGCCTGTGACCTGGTCACGCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGC AACAATGGAAGCCTCCTCATTACCATTGAGGACGTGAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCT GAACTCGTGCTGCCCAACCGGGAGGTGGCTTCTGTCCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTC CGAGTAGACTTCATCTCTAAGGACGGGGCCACCATCCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCT GGGAGCATTCAGCCGGTGACCAGCCTCGACTCCACTCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGT CCTTTCCTGGAAGCCACCACCACCCTGAATCTCTTCACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAG GTGGGCGCCAACAGACAGGCGATTAATGCGGCTCTTACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCT GCAGCTCGGGCCCGACCTCACTCCTACCTCGATGCCTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATG ATCCGGAATGATCAGGACTCGCTGACGCAGCTGCTGCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCG AAACAGCTCATCAGTGTCATCATAGGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAG AGCTACAACCGGAAGCTTCAAGCTATGAAGGCTGCCAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCA GGGACTAACATGTACAACACTGAGCGAGCCAACCCCATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAAT GACCTGGACTCTGTCAGCGTCAACTCCCTGGACGACAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCA CACACACCACCAGAGCCAGATCCAGAGCCCCTGAGCGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCC TACACCAACGCTGGCCTGGACACCACGGACCTGTGACAGGGGCCCCCACTCTTCTGGACCCCTTGAAGAGGCCCTACCACACCCTAACTG CACCTGTCTCCCTGGAGATGAAAATATATGACGCTGCCCTGCCTCCTGCTTTTGGCCAATCACGGCAGACAGGGGTTGGGGAAATATTTT ATTACCAATGTATACTGTGACAGTTTGTAGCCAAAAACTGCGGCTGGAGGGGTGGGGACGGGACACTGAGTGGTCACAAGGGACTTGGGC >17309_17309_3_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320895_CDHR2_chr5_176008344_ENST00000510636_length(amino acids)=869AA_BP=164 MRGGRAGGAGRGAAMWSGRSSFTSLVVGVFVVYVVHTCWVMYGIVYTRPCSGDANCIQPYLARRPKLQLSVYTTTRSHLGAENNIDLVLN VEDFDVESKFERTVNVSVPKKTRNNGTLYAYIFLHHAGVLPWHDGKQVHLVSPLTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLL FNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGV LVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDV NDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVT LVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATI PFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAAL TQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGV ALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDD -------------------------------------------------------------- >17309_17309_4_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320927_CDHR2_chr5_176008344_ENST00000261944_length(transcript)=2707nt_BP=496nt GCTGAGAGGCGGGCGGGCCGGGGGCGCCGGGCGCGGGGCCGCCATGTGGAGCGGCCGCAGCTCCTTCACCAGCTTGGTGGTGGGCGTGTT CGTGGTCTACGTGGTGCACACCTGCTGGGTCATGTACGGCATCGTCTACACCCGCCCGTGCTCCGGCGACGCCAACTGCATCCAGCCCTA CCTGGCGCGGCGGCCCAAGCTGCAGCTGAGCGTGTACACCACGACGAGGTCCCACCTGGGTGCTGAGAACAACATCGACCTGGTCTTGAA TGTGGAAGACTTTGATGTGGAGTCCAAATTTGAAAGGACAGTTAATGTTTCTGTACCAAAGAAAACGAGAAACAATGGGACGCTGTATGC CTACATCTTCCTCCATCACGCTGGGGTCCTGCCGTGGCACGACGGGAAGCAGGTGCACCTGGTCAGTCCTCTGACCACCTACATGGTCCC CAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGACAATGATGAGCCGGGCACCAACAACAGCCGTCTGCT CTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACAGGGCTCCTCAGAAACCTGGGGCCCCTGGACAGAGA GGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGACTGCGGCGAGCCTGTCCTCGGCACCAAAGTCAATGT CACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGCTACAACTTTACGGTGAAGGAGGAGGATCCAGGAGT GCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGCATCAGCTTCAGCCTGTCGGGGAGTGGTGCCAACTA CTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGGCTGCCCCCGGACGTGAGCCTGGATTACGAGACACA GCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAGACCATAGTAGACGTCTGCGTGAATGTGAAAGACGT GAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCTGAGAATGGCTCACAGCACGGCCAGGTGGCTGTGGT GGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATTCTCTGCACCAAGGCCGGGGTCGATGTGGGCAGCCT ATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGCAAAGCCATCGACTACGAGGCCTGTGACCTGGTCAC GCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGCAACAATGGAAGCCTCCTCATTACCATTGAGGACGT GAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCTGAACTCGTGCTGCCCAACCGGGAGGTGGCTTCTGT CCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTCCGAGTAGACTTCATCTCTAAGGACGGGGCCACCAT CCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCTGGGAGCATTCAGCCGGTGACCAGCCTCGACTCCAC TCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGTCCTTTCCTGGAAGCCACCACCACCCTGAATCTCTT CACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAGGTGGGCGCCAACAGACAGGCGATTAATGCGGCTCT TACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCTGCAGCTCGGGCCCGACCTCACTCCTACCTCGATGC CTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATGATCCGGAATGATCAGGACTCGCTGACGCAGCTGCT GCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCGAAACAGCTCATCAGTGTCATCATAGGATTGGGAGT GGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAGAGCTACAACCGGAAGCTTCAAGCTATGAAGGCTGC CAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCAGGGACTAACATGTACAACACTGAGCGAGCCAACCC CATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAATGACCTGGACTCTGTCAGCGTCAACTCCCTGGACGA CAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCACACACACCACCAGAGCCAGATCCAGAGCCCCTGAG CGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCCTACACCAACGCTGGCCTGGACACCACGGACCTGTG ACAGGGGCCCCCACTCTTCTGGACCCCTTGAAGAGGCCCTACCACACCCTAACTGCACCTGTCTCCCTGGAGATGAAAATATATGACGCT >17309_17309_4_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320927_CDHR2_chr5_176008344_ENST00000261944_length(amino acids)=869AA_BP=164 LRGGRAGGAGRGAAMWSGRSSFTSLVVGVFVVYVVHTCWVMYGIVYTRPCSGDANCIQPYLARRPKLQLSVYTTTRSHLGAENNIDLVLN VEDFDVESKFERTVNVSVPKKTRNNGTLYAYIFLHHAGVLPWHDGKQVHLVSPLTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLL FNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGV LVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDV NDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVT LVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATI PFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAAL TQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGV ALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDD -------------------------------------------------------------- >17309_17309_5_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320927_CDHR2_chr5_176008344_ENST00000506348_length(transcript)=2636nt_BP=496nt GCTGAGAGGCGGGCGGGCCGGGGGCGCCGGGCGCGGGGCCGCCATGTGGAGCGGCCGCAGCTCCTTCACCAGCTTGGTGGTGGGCGTGTT CGTGGTCTACGTGGTGCACACCTGCTGGGTCATGTACGGCATCGTCTACACCCGCCCGTGCTCCGGCGACGCCAACTGCATCCAGCCCTA CCTGGCGCGGCGGCCCAAGCTGCAGCTGAGCGTGTACACCACGACGAGGTCCCACCTGGGTGCTGAGAACAACATCGACCTGGTCTTGAA TGTGGAAGACTTTGATGTGGAGTCCAAATTTGAAAGGACAGTTAATGTTTCTGTACCAAAGAAAACGAGAAACAATGGGACGCTGTATGC CTACATCTTCCTCCATCACGCTGGGGTCCTGCCGTGGCACGACGGGAAGCAGGTGCACCTGGTCAGTCCTCTGACCACCTACATGGTCCC CAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGACAATGATGAGCCGGGCACCAACAACAGCCGTCTGCT CTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACAGGGCTCCTCAGAAACCTGGGGCCCCTGGACAGAGA GGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGACTGCGGCGAGCCTGTCCTCGGCACCAAAGTCAATGT CACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGCTACAACTTTACGGTGAAGGAGGAGGATCCAGGAGT GCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGCATCAGCTTCAGCCTGTCGGGGAGTGGTGCCAACTA CTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGGCTGCCCCCGGACGTGAGCCTGGATTACGAGACACA GCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAGACCATAGTAGACGTCTGCGTGAATGTGAAAGACGT GAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCTGAGAATGGCTCACAGCACGGCCAGGTGGCTGTGGT GGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATTCTCTGCACCAAGGCCGGGGTCGATGTGGGCAGCCT ATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGCAAAGCCATCGACTACGAGGCCTGTGACCTGGTCAC GCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGCAACAATGGAAGCCTCCTCATTACCATTGAGGACGT GAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCTGAACTCGTGCTGCCCAACCGGGAGGTGGCTTCTGT CCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTCCGAGTAGACTTCATCTCTAAGGACGGGGCCACCAT CCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCTGGGAGCATTCAGCCGGTGACCAGCCTCGACTCCAC TCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGTCCTTTCCTGGAAGCCACCACCACCCTGAATCTCTT CACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAGGTGGGCGCCAACAGACAGGCGATTAATGCGGCTCT TACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCTGCAGCTCGGGCCCGACCTCACTCCTACCTCGATGC CTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATGATCCGGAATGATCAGGACTCGCTGACGCAGCTGCT GCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCGAAACAGCTCATCAGTGTCATCATAGGATTGGGAGT GGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAGAGCTACAACCGGAAGCTTCAAGCTATGAAGGCTGC CAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCAGGGACTAACATGTACAACACTGAGCGAGCCAACCC CATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAATGACCTGGACTCTGTCAGCGTCAACTCCCTGGACGA CAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCACACACACCACCAGAGCCAGATCCAGAGCCCCTGAG CGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCCTACACCAACGCTGGCCTGGACACCACGGACCTGTG >17309_17309_5_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320927_CDHR2_chr5_176008344_ENST00000506348_length(amino acids)=869AA_BP=164 LRGGRAGGAGRGAAMWSGRSSFTSLVVGVFVVYVVHTCWVMYGIVYTRPCSGDANCIQPYLARRPKLQLSVYTTTRSHLGAENNIDLVLN VEDFDVESKFERTVNVSVPKKTRNNGTLYAYIFLHHAGVLPWHDGKQVHLVSPLTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLL FNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGV LVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDV NDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVT LVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATI PFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAAL TQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGV ALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDD -------------------------------------------------------------- >17309_17309_6_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320927_CDHR2_chr5_176008344_ENST00000510636_length(transcript)=2913nt_BP=496nt GCTGAGAGGCGGGCGGGCCGGGGGCGCCGGGCGCGGGGCCGCCATGTGGAGCGGCCGCAGCTCCTTCACCAGCTTGGTGGTGGGCGTGTT CGTGGTCTACGTGGTGCACACCTGCTGGGTCATGTACGGCATCGTCTACACCCGCCCGTGCTCCGGCGACGCCAACTGCATCCAGCCCTA CCTGGCGCGGCGGCCCAAGCTGCAGCTGAGCGTGTACACCACGACGAGGTCCCACCTGGGTGCTGAGAACAACATCGACCTGGTCTTGAA TGTGGAAGACTTTGATGTGGAGTCCAAATTTGAAAGGACAGTTAATGTTTCTGTACCAAAGAAAACGAGAAACAATGGGACGCTGTATGC CTACATCTTCCTCCATCACGCTGGGGTCCTGCCGTGGCACGACGGGAAGCAGGTGCACCTGGTCAGTCCTCTGACCACCTACATGGTCCC CAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGACAATGATGAGCCGGGCACCAACAACAGCCGTCTGCT CTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACAGGGCTCCTCAGAAACCTGGGGCCCCTGGACAGAGA GGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGACTGCGGCGAGCCTGTCCTCGGCACCAAAGTCAATGT CACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGCTACAACTTTACGGTGAAGGAGGAGGATCCAGGAGT GCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGCATCAGCTTCAGCCTGTCGGGGAGTGGTGCCAACTA CTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGGCTGCCCCCGGACGTGAGCCTGGATTACGAGACACA GCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAGACCATAGTAGACGTCTGCGTGAATGTGAAAGACGT GAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCTGAGAATGGCTCACAGCACGGCCAGGTGGCTGTGGT GGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATTCTCTGCACCAAGGCCGGGGTCGATGTGGGCAGCCT ATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGCAAAGCCATCGACTACGAGGCCTGTGACCTGGTCAC GCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGCAACAATGGAAGCCTCCTCATTACCATTGAGGACGT GAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCTGAACTCGTGCTGCCCAACCGGGAGGTGGCTTCTGT CCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTCCGAGTAGACTTCATCTCTAAGGACGGGGCCACCAT CCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCTGGGAGCATTCAGCCGGTGACCAGCCTCGACTCCAC TCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGTCCTTTCCTGGAAGCCACCACCACCCTGAATCTCTT CACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAGGTGGGCGCCAACAGACAGGCGATTAATGCGGCTCT TACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCTGCAGCTCGGGCCCGACCTCACTCCTACCTCGATGC CTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATGATCCGGAATGATCAGGACTCGCTGACGCAGCTGCT GCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCGAAACAGCTCATCAGTGTCATCATAGGATTGGGAGT GGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAGAGCTACAACCGGAAGCTTCAAGCTATGAAGGCTGC CAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCAGGGACTAACATGTACAACACTGAGCGAGCCAACCC CATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAATGACCTGGACTCTGTCAGCGTCAACTCCCTGGACGA CAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCACACACACCACCAGAGCCAGATCCAGAGCCCCTGAG CGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCCTACACCAACGCTGGCCTGGACACCACGGACCTGTG ACAGGGGCCCCCACTCTTCTGGACCCCTTGAAGAGGCCCTACCACACCCTAACTGCACCTGTCTCCCTGGAGATGAAAATATATGACGCT GCCCTGCCTCCTGCTTTTGGCCAATCACGGCAGACAGGGGTTGGGGAAATATTTTATTACCAATGTATACTGTGACAGTTTGTAGCCAAA AACTGCGGCTGGAGGGGTGGGGACGGGACACTGAGTGGTCACAAGGGACTTGGGCTCACAGCACAGGGGGGACAAGGGGCTGGAGAGGGT >17309_17309_6_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000320927_CDHR2_chr5_176008344_ENST00000510636_length(amino acids)=869AA_BP=164 LRGGRAGGAGRGAAMWSGRSSFTSLVVGVFVVYVVHTCWVMYGIVYTRPCSGDANCIQPYLARRPKLQLSVYTTTRSHLGAENNIDLVLN VEDFDVESKFERTVNVSVPKKTRNNGTLYAYIFLHHAGVLPWHDGKQVHLVSPLTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLL FNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGV LVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDV NDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVT LVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATI PFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAAL TQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGV ALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDD -------------------------------------------------------------- >17309_17309_7_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000507807_CDHR2_chr5_176008344_ENST00000261944_length(transcript)=2279nt_BP=68nt CTCTGACCACCTACATGGTCCCCAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGACAATGATGAGCCGG GCACCAACAACAGCCGTCTGCTCTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACAGGGCTCCTCAGAA ACCTGGGGCCCCTGGACAGAGAGGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGACTGCGGCGAGCCTG TCCTCGGCACCAAAGTCAATGTCACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGCTACAACTTTACGG TGAAGGAGGAGGATCCAGGAGTGCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGCATCAGCTTCAGCC TGTCGGGGAGTGGTGCCAACTACTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGGCTGCCCCCGGACG TGAGCCTGGATTACGAGACACAGCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAGACCATAGTAGACG TCTGCGTGAATGTGAAAGACGTGAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCTGAGAATGGCTCAC AGCACGGCCAGGTGGCTGTGGTGGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATTCTCTGCACCAAGG CCGGGGTCGATGTGGGCAGCCTATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGCAAAGCCATCGACT ACGAGGCCTGTGACCTGGTCACGCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGCAACAATGGAAGCC TCCTCATTACCATTGAGGACGTGAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCTGAACTCGTGCTGC CCAACCGGGAGGTGGCTTCTGTCCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTCCGAGTAGACTTCA TCTCTAAGGACGGGGCCACCATCCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCTGGGAGCATTCAGC CGGTGACCAGCCTCGACTCCACTCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGTCCTTTCCTGGAAG CCACCACCACCCTGAATCTCTTCACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAGGTGGGCGCCAACA GACAGGCGATTAATGCGGCTCTTACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCTGCAGCTCGGGCCC GACCTCACTCCTACCTCGATGCCTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATGATCCGGAATGATC AGGACTCGCTGACGCAGCTGCTGCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCGAAACAGCTCATCA GTGTCATCATAGGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAGAGCTACAACCGGA AGCTTCAAGCTATGAAGGCTGCCAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCAGGGACTAACATGT ACAACACTGAGCGAGCCAACCCCATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAATGACCTGGACTCTG TCAGCGTCAACTCCCTGGACGACAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCACACACACCACCAG AGCCAGATCCAGAGCCCCTGAGCGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCCTACACCAACGCTG GCCTGGACACCACGGACCTGTGACAGGGGCCCCCACTCTTCTGGACCCCTTGAAGAGGCCCTACCACACCCTAACTGCACCTGTCTCCCT >17309_17309_7_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000507807_CDHR2_chr5_176008344_ENST00000261944_length(amino acids)=726AA_BP=21 LTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLLFNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPV LGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGVLVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDV SLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDVNDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKA GVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVTLVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLP NREVASVRARDDDSGNNGVILFSILRVDFISKDGATIPFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEA TTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAALTQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQ DSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGVALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMY NTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDDNSVDVDKNSQEIKEHRPPHTPPEPDPEPLSVVLLGRQAGASGQLEGPSYTNAG -------------------------------------------------------------- >17309_17309_8_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000507807_CDHR2_chr5_176008344_ENST00000506348_length(transcript)=2208nt_BP=68nt CTCTGACCACCTACATGGTCCCCAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGACAATGATGAGCCGG GCACCAACAACAGCCGTCTGCTCTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACAGGGCTCCTCAGAA ACCTGGGGCCCCTGGACAGAGAGGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGACTGCGGCGAGCCTG TCCTCGGCACCAAAGTCAATGTCACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGCTACAACTTTACGG TGAAGGAGGAGGATCCAGGAGTGCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGCATCAGCTTCAGCC TGTCGGGGAGTGGTGCCAACTACTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGGCTGCCCCCGGACG TGAGCCTGGATTACGAGACACAGCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAGACCATAGTAGACG TCTGCGTGAATGTGAAAGACGTGAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCTGAGAATGGCTCAC AGCACGGCCAGGTGGCTGTGGTGGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATTCTCTGCACCAAGG CCGGGGTCGATGTGGGCAGCCTATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGCAAAGCCATCGACT ACGAGGCCTGTGACCTGGTCACGCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGCAACAATGGAAGCC TCCTCATTACCATTGAGGACGTGAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCTGAACTCGTGCTGC CCAACCGGGAGGTGGCTTCTGTCCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTCCGAGTAGACTTCA TCTCTAAGGACGGGGCCACCATCCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCTGGGAGCATTCAGC CGGTGACCAGCCTCGACTCCACTCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGTCCTTTCCTGGAAG CCACCACCACCCTGAATCTCTTCACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAGGTGGGCGCCAACA GACAGGCGATTAATGCGGCTCTTACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCTGCAGCTCGGGCCC GACCTCACTCCTACCTCGATGCCTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATGATCCGGAATGATC AGGACTCGCTGACGCAGCTGCTGCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCGAAACAGCTCATCA GTGTCATCATAGGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAGAGCTACAACCGGA AGCTTCAAGCTATGAAGGCTGCCAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCAGGGACTAACATGT ACAACACTGAGCGAGCCAACCCCATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAATGACCTGGACTCTG TCAGCGTCAACTCCCTGGACGACAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCACACACACCACCAG AGCCAGATCCAGAGCCCCTGAGCGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCCTACACCAACGCTG >17309_17309_8_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000507807_CDHR2_chr5_176008344_ENST00000506348_length(amino acids)=726AA_BP=21 LTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLLFNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPV LGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGVLVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDV SLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDVNDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKA GVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVTLVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLP NREVASVRARDDDSGNNGVILFSILRVDFISKDGATIPFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEA TTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAALTQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQ DSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGVALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMY NTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDDNSVDVDKNSQEIKEHRPPHTPPEPDPEPLSVVLLGRQAGASGQLEGPSYTNAG -------------------------------------------------------------- >17309_17309_9_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000507807_CDHR2_chr5_176008344_ENST00000510636_length(transcript)=2485nt_BP=68nt CTCTGACCACCTACATGGTCCCCAAGCCAGAAGAAATCAACCTGCTCACCGGGGAGTCTGATACACAGGCCCACGACAATGATGAGCCGG GCACCAACAACAGCCGTCTGCTCTTCAACCTGCTGCCTGGCCCCTACAGCCACAACTTCTCCTTGGACCCTGACACAGGGCTCCTCAGAA ACCTGGGGCCCCTGGACAGAGAGGCCATCGACCCCGCCCTGGAGGGCCGCATTGTGCTGACAGTGCTTGTGTCTGACTGCGGCGAGCCTG TCCTCGGCACCAAAGTCAATGTCACCATCACTGTGGAGGACATCAATGATAACCTGCCCATCTTCAATCAGTCCAGCTACAACTTTACGG TGAAGGAGGAGGATCCAGGAGTGCTAGTGGGCGTGGTGAAGGCCTGGGACGCGGACCAGACGGAAGCCAACAACCGCATCAGCTTCAGCC TGTCGGGGAGTGGTGCCAACTACTTCATGATCCGAGGCTTGGTGCTGGGGGCTGGGTGGGCTGAGGGCTACCTCCGGCTGCCCCCGGACG TGAGCCTGGATTACGAGACACAGCCCGTCTTCAACTTGACAGTGAGTGCTGAGAACCCAGACCCCCAGGGGGGTGAGACCATAGTAGACG TCTGCGTGAATGTGAAAGACGTGAACGACAATCCCCCCACCCTGGATGTAGCCTCACTCCGGGGCATCCGTGTGGCTGAGAATGGCTCAC AGCACGGCCAGGTGGCTGTGGTGGTTGCCTCGGATGTGGACACCAGTGCCCAGCTGGAGATACAGCTTGTGAACATTCTCTGCACCAAGG CCGGGGTCGATGTGGGCAGCCTATGCTGGGGCTGGTTCTCAGTGGCGGCCAACGGCTCTGTGTACATCAACCAGAGCAAAGCCATCGACT ACGAGGCCTGTGACCTGGTCACGCTGGTTGTGCGGGCCTGTGACCTAGCCACGGACCCCGGCTTCCAGGCCTACAGCAACAATGGAAGCC TCCTCATTACCATTGAGGACGTGAATGACAATGCACCCTATTTTCTGCCTGAGAATAAGACTTTTGTGATCATCCCTGAACTCGTGCTGC CCAACCGGGAGGTGGCTTCTGTCCGGGCCAGAGACGATGATTCAGGGAACAATGGCGTCATCCTGTTCTCCATCCTCCGAGTAGACTTCA TCTCTAAGGACGGGGCCACCATCCCTTTCCAGGGTGTCTTCTCGATCTTCACCTCCTCCGAGGCCGACGTGTTCGCTGGGAGCATTCAGC CGGTGACCAGCCTCGACTCCACTCTCCAAGGCACCTACCAAGTGACAGTCCAGGCCAGGGACAGACCTTCCTTGGGTCCTTTCCTGGAAG CCACCACCACCCTGAATCTCTTCACCGTGGACCAGAGTTACCGCTCGCGGCTGCAGTTCTCCACACCGAAGGAGGAGGTGGGCGCCAACA GACAGGCGATTAATGCGGCTCTTACCCAGGCAACCAGGACTACAGTATACATTGTGGACATTCAGGACATAGATTCTGCAGCTCGGGCCC GACCTCACTCCTACCTCGATGCCTACTTTGTCTTCCCCAATGGGTCAGCCCTGACCCTTGATGAGCTGAGTGTGATGATCCGGAATGATC AGGACTCGCTGACGCAGCTGCTGCAGCTGGGGCTGGTGGTGCTGGGCTCCCAGGAGAGCCAGGAGTCAGACCTGTCGAAACAGCTCATCA GTGTCATCATAGGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTGCGGAAGAGCTACAACCGGA AGCTTCAAGCTATGAAGGCTGCCAAGGAGGCCAGGAAGACAGCAGCAGGGGTGATGCCCTCAGCCCCTGCCATCCCAGGGACTAACATGT ACAACACTGAGCGAGCCAACCCCATGCTGAACCTCCCCAACAAAGACCTGGGCTTGGAGTACCTCTCTCCCTCCAATGACCTGGACTCTG TCAGCGTCAACTCCCTGGACGACAACTCTGTGGATGTGGACAAGAACAGTCAGGAAATCAAGGAGCACAGGCCACCACACACACCACCAG AGCCAGATCCAGAGCCCCTGAGCGTGGTCCTGTTAGGACGGCAGGCAGGCGCAAGTGGACAGCTGGAGGGGCCATCCTACACCAACGCTG GCCTGGACACCACGGACCTGTGACAGGGGCCCCCACTCTTCTGGACCCCTTGAAGAGGCCCTACCACACCCTAACTGCACCTGTCTCCCT GGAGATGAAAATATATGACGCTGCCCTGCCTCCTGCTTTTGGCCAATCACGGCAGACAGGGGTTGGGGAAATATTTTATTACCAATGTAT ACTGTGACAGTTTGTAGCCAAAAACTGCGGCTGGAGGGGTGGGGACGGGACACTGAGTGGTCACAAGGGACTTGGGCTCACAGCACAGGG >17309_17309_9_CLPTM1L-CDHR2_CLPTM1L_chr5_1341786_ENST00000507807_CDHR2_chr5_176008344_ENST00000510636_length(amino acids)=726AA_BP=21 LTTYMVPKPEEINLLTGESDTQAHDNDEPGTNNSRLLFNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPV LGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGVLVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDV SLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDVNDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKA GVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVTLVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLP NREVASVRARDDDSGNNGVILFSILRVDFISKDGATIPFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEA TTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAALTQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQ DSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGVALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMY NTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDDNSVDVDKNSQEIKEHRPPHTPPEPDPEPLSVVLLGRQAGASGQLEGPSYTNAG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CLPTM1L-CDHR2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CLPTM1L-CDHR2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CLPTM1L-CDHR2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies